Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression

Insulin‐dependent diabetes mellitus can be transferred into young irradiated non‐obese diabetic (NOD) mice by spleen cells from a diabetic NOD donor. T cells (both L3T4+ and Ly‐2+) enter the pancreas 2 weeks following transfer. They are present initially at peri‐islet locations but progressively infiltrate the islet with accompanying β cell destruction. The infiltrate is heterogeneous with respect to Vβ usage. Inflammatory macrophages (Mac‐1+, F4/80+) can be detected at peri‐islet locations at 1 week after transfer and continue to be recruited during the disease process. Their presence at the initiation of disease suggests that their primary function may be autoantigen presentation. Increased expression of major histocompatibility complex (MHC) class I molecules is observed on both endocrine and exocrine tissue in areas of infra‐islet infiltration. MHC class II and ICAM‐1 expression was restricted to the cells constituting the inflammatory infiltrate. Expression of these molecules was not observed on β cells implying that presentation of autoantigen by the β cell itself does not play a role in the β cell destruction in NOD mice.

[1]  K. Grossmann,et al.  The plant oncogene rolC is responsible for the release of cytokinins from glucoside conjugates. , 1991, The EMBO journal.

[2]  D. Kioussis,et al.  Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain , 1990, Nature.

[3]  F. Ramsdell,et al.  Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. , 1990, Science.

[4]  B. Formby,et al.  Autologous CD4 T-cell responses to ectopic class II major histocompatibility complex antigen-expressing single-cell islet cells: an in vitro insight into the pathogenesis of lymphocytic insulitis in nonobese diabetic mice. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Eisenbarth,et al.  Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. , 1990, Annual review of immunology.

[6]  F. Takei,et al.  Molecular cloning of murine intercellular adhesion molecule (ICAM‐1). , 1989, The EMBO journal.

[7]  P. Bedossa,et al.  Syngeneic t cell transfer of diabetes into nod newborn mice: in situ studies of the autoimmune steps leading to insulin‐producing cell destruction , 1989, European journal of immunology.

[8]  M. Charles,et al.  Macrophage-Mediated Islet Cell Cytotoxicity in BB Rats , 1989, Diabetes.

[9]  H. Kolb,et al.  Spontaneous cytotoxicity of macrophages against pancreatic islet cells. , 1989, Journal of immunology.

[10]  A. Boyd,et al.  Intercellular adhesion molecule 1 is induced on isolated endocrine islet cells by cytokines but not by reovirus infection. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[11]  S. Gordon,et al.  Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody , 1989, The Journal of experimental medicine.

[12]  T. Seemayer,et al.  IDDM in BB Rats: Enhanced MHC Class I Heavy-Chain Gene Expression in Pancreatic Islets , 1988, Diabetes.

[13]  L. Harrison,et al.  IFN-gamma and tumor necrosis factor-alpha. Cytotoxicity to murine islets of Langerhans. , 1988, Journal of immunology.

[14]  P. in’t Veld,et al.  In situ analysis of pancreatic islets in rats developing diabetes. Appearance of nonendocrine cells with surface MHC class II antigens and cytoplasmic insulin immunoreactivity. , 1988, The Journal of clinical investigation.

[15]  A. Cooke,et al.  Distinct Macrophage Subpopulations in Pancreas of Prediabetic BB/E Rats: Possible Role for Macrophages in Pathogenesis of IDDM , 1988, Diabetes.

[16]  B. Charlton,et al.  Administration of Silica Particles or Anti-Lyt2 Antibody Prevents β-Cell Destruction in NOD Mice Given Cyclophosphamide , 1988, Diabetes.

[17]  G. Morahan,et al.  Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic β cells , 1988, Nature.

[18]  R. Zinkernagel,et al.  T-cell receptor Vβ use predicts reactivity and tolerance to Mlsa- encoded antigens , 1988, Nature.

[19]  N. Hogg,et al.  The function of human intercellular adhesion molecule‐1 (ICAM‐1) in the generation of an immune response , 1988, European journal of immunology.

[20]  H. Kolb,et al.  Evidence of IgG Autoantibodies Against Human Proinsulin in Patients With IDDM Before Insulin Treatment , 1988, Diabetes.

[21]  A. Rabinovitch,et al.  Destruction of Rat Islet Cell Monolayers by Cytokines: Synergistic Interactions of Interferon-γ, Tumor Necrosis Factor, Lymphotoxin, and Interleukin 1 , 1988, Diabetes.

[22]  C. Boitard,et al.  Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells , 1987, The Journal of experimental medicine.

[23]  S. Gordon,et al.  The mouse macrophage-specific glycoprotein defined by monoclonal antibody F4/80: characterization, biosynthesis and demonstration of a rat analogue. , 1987, Immunology.

[24]  K. Yamamura,et al.  Prevention of autoimmune insulitis by expression of I–E molecules in NOD mice , 1987, Nature.

[25]  K. Lafferty,et al.  Combined Treatment With Nicotinamide and Desferrioxamine Prevents Islet Allograft Destruction in NOD Mice , 1986, Diabetes.

[26]  L. Wicker,et al.  Transfer of Autoimmune Diabetes Mellitus with Splenocytes from Nonobese Diabetic (NOD) Mice , 1986, Diabetes.

[27]  J. Nerup,et al.  Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. , 1986, Science.

[28]  G. Wong,et al.  Interferon-γ Enhances the Expression of the Major Histocompatibility Class I Antigens on Mouse Pancreatic Beta Cells , 1985, Diabetes.

[29]  A. Michael,et al.  Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[30]  H. Kolb,et al.  Administration of Silica Prevents Diabetes in BB-Rats , 1985, Diabetes.

[31]  H. Waldmann,et al.  Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo , 1984, Nature.

[32]  P. Marrack,et al.  The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype , 1984, The Journal of experimental medicine.

[33]  E. Leiter,et al.  Macrophage-mediated cytotoxicity against cultured pancreatic islet cells. , 1984, Transplantation.

[34]  R. Schreiber,et al.  Anti-mac-1 Selectively Inhibits the Mouse and Human Type Three Complement Receptor* , 2003 .

[35]  T. Springer,et al.  Characterization of an anti-H-2 monoclonal antibody and its use in large-scale antigen purification. , 1981, Journal of immunology.

[36]  J. Austyn,et al.  Expression of the macrophage-specific antigen F4/80 during differentiation of mouse bone marrow cells in culture , 1981, The Journal of experimental medicine.

[37]  S. Gordon,et al.  F4/80, a monoclonal antibody directed specifically against the mouse macrophage , 1981, European journal of immunology.

[38]  Y. Tochino,et al.  Breeding of a non-obese, diabetic strain of mice. , 1980, Jikken dobutsu. Experimental animals.

[39]  W. McMaster,et al.  Identification of Ia glycoproteins in rat thymus and purification from rat spleen , 1979, European journal of immunology.

[40]  A. Lang Kinship and Marriage in Early Arabia , 1886, Nature.